These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 12719200)
1. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200 [TBL] [Abstract][Full Text] [Related]
2. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
3. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183 [TBL] [Abstract][Full Text] [Related]
4. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144 [TBL] [Abstract][Full Text] [Related]
6. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ; N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation period in idiopathic venous thromboembolism. How long is enough? Farraj RS Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686 [TBL] [Abstract][Full Text] [Related]
8. Outpatient management of anticoagulation therapy. du Breuil AL; Umland EM Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618 [TBL] [Abstract][Full Text] [Related]
9. Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care. Aspinall SL; DeSanzo BE; Trilli LE; Good CB J Gen Intern Med; 2005 Nov; 20(11):1008-13. PubMed ID: 16307625 [TBL] [Abstract][Full Text] [Related]
10. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W; N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010 [TBL] [Abstract][Full Text] [Related]
11. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704 [TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants. DeLoughery TG Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670 [TBL] [Abstract][Full Text] [Related]
13. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Huo MH; Muntz J Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383 [TBL] [Abstract][Full Text] [Related]
14. [Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications]. Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Khasanova ZB; Postnov AIu; Kirienko AI Ter Arkh; 2011; 83(12):43-8. PubMed ID: 22416444 [TBL] [Abstract][Full Text] [Related]
15. The Janus face of thromboprophylaxis in patients with high risk for both thrombosis and bleeding during intracranial surgery: report of five exemplary cases. Niemi T; Silvasti-Lundell M; Armstrong E; Hernesniemi J Acta Neurochir (Wien); 2009 Oct; 151(10):1289-94. PubMed ID: 19513580 [TBL] [Abstract][Full Text] [Related]
16. Long-term management of patients after venous thromboembolism. Kearon C Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. Prandoni P; Carnovali M; Marchiori A; Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264 [TBL] [Abstract][Full Text] [Related]
18. Risk of thromboembolism with short-term interruption of warfarin therapy. Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197 [TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD; Johnson JA; Turpie AG Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic anticoagulation in the trauma patient: is it safe? Golob JF; Sando MJ; Kan JC; Yowler CJ; Malangoni MA; Claridge JA Surgery; 2008 Oct; 144(4):591-6; discussion 596-7. PubMed ID: 18847643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]